42: Shen J, Lu L, Chen Z, Guo W, Wang S, Liu Z, Gong X, Qi Y, Jin R, Zhang C, (2025). Multi-omics analysis constructs a novel neuroendocrine prostate cancer classifier and classification system. Sci Rep 15:13901.
Abstract
41: Izutsu R, Osaki M, Seong H, Sato R, Okada F, (2025). Hepatic Stellate Cells Activated by Cancer Cell-derived AMIGO2-containing Small Extracellular Vesicles Promote Cancer Cell Migration by Producing IL-8. Anticancer Res 45:1435-1446.
Abstract
40: Seong H, Kanda Y, Izutsu R, Jehung JP, Hamada J, Osaki M, Okamoto K, Okada F, (2024). Prevention of liver metastasis via the pharmacological suppression of AMIGO2 expression in tumor cells. Sci Rep 14:28183.
Abstract
39: Yong Y, Demmler R, Zohud BA, Fang Q, Zhang T, Zhou Y, Petter K, Flierl C, Gass T, Geppert CI, Merkel S, Schellerer VS, Naschberger E, Sturzl M, (2025). AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes. J Pathol 265:14-25.
Abstract
38: Izutsu R, Osaki M, Seong H, Ogata S, Sato R, Hamada JI, Okada F, (2024). AMIGO2 enhances the invasive potential of colorectal cancer by inducing EMT. Cancer Gene Ther 31:1786-1795.
Abstract
37: Tian Z, Zhou D, Jiang R, Zhou B, (2024). Role of AMIGO2 in cancer progression: Novel insights (Review). Oncol Lett 28:434.
Abstract
36: Yamaguchi N, Wu YG, Ravetch E, Takahashi M, Khan AG, Hayashi A, Mei W, Hsu D, Umeda S, de Stanchina E, Lorenz IC, Iacobuzio-Donahue CA, Tavazoie SF, (2024). A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1alpha Nuclear Retention. Cancer Discov 14:2489-2508.
Abstract
35: Han D, Xiong B, Zhang X, Chen C, Yao Z, Wu H, Cao J, Li J, Li P, Wang Z, Tian J, (2024). Knockdown of AMIGO2 suppresses proliferation and migration through regulating PPAR-gamma in bladder cancer. Hereditas 161:21.
Abstract
34: Iida Y, Osaki M, Sato S, Izutsu R, Seong H, Komatsu H, Taniguchi F, Okada F, (2024). AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells. Int J Clin Oncol 29:1354-1363.
Abstract
33: Qiu Y, Tian Z, Miao TY, Shen L, Chen J, Li PF, Zhu ZX, Zhu ZF, Wu WJ, Xu X, Shen WG, (2024). The METTL3-m(6)A-YTHDC1-AMIGO2 axis contributes to cell proliferation and migration in esophageal squamous cell carcinoma. Gene 908:148281.
Abstract
32: Chen S, Du W, Feng K, Liu K, Li C, Li S, Yin H, (2024). AMIGO2 is a pivotal therapeutic target related to M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Aging (Albany NY) 16:1111-1127.
Abstract
31: Lin S, Cao Y, Zhu K, Yang C, Zhu X, Zhang H, Zhang R, (2023). Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma. J Hepatocell Carcinoma 10:1749-1765.
Abstract
30: Chen LK, Lin SP, Xie YH, Tan XP, Xiong BH, Zeng XF, Zhu CR, Cao SY, Ye XY, Liu HJ, Wu XP, (2023). AMIGO2 attenuates innate cisplatin sensitivity by suppression of GSDME-conferred pyroptosis in non-small cell lung cancer. J Cell Mol Med 27:2412-2423.
Abstract
29: Iida Y, Osaki M, Sato S, Izutsu R, Seong H, Okawa M, Osaku D, Komatsu H, Taniguchi F, Okada F, (2023). AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk. Mol Clin Oncol 19:56.
Abstract
28: Du Y, Jiang W, Hou S, Chen Z, Zhou W, (2023). A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer. Biomed Res Int 2023:3419401.
Abstract
27: Liu C, Liu D, Wang F, Liu Y, Xie J, Xie J, Xie Y, (2022). Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Front Immunol 13:1038927.
Abstract
26: Han Z, Feng Y, Deng Y, Tang Z, Cai S, Zhuo Y, Liang Y, Ye J, Cai Z, Yang S, Liang Y, Hon CT, Chen J, Zhong W, (2022). Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer. Transl Androl Urol 11:914-928.
Abstract
25: Izutsu R, Osaki M, Jehung JP, Seong HK, Okada F, (2022). Liver Metastasis Formation Is Defined by AMIGO2 Expression via Adhesion to Hepatic Endothelial Cells in Human Gastric and Colorectal Cancer Cells. Pathol Res Pract 237:154015.
Abstract
24: Goto K, Morimoto M, Osaki M, Tanio A, Izutsu R, Fujiwara Y, Okada F, (2022). The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients. BMC Cancer 22:280.
Abstract
23: Goto K, Osaki M, Izutsu R, Tanaka H, Sasaki R, Tanio A, Satofuka H, Kazuki Y, Yamamoto M, Kugoh H, Ito H, Oshimura M, Fujiwara Y, Okada F, (2022). Establishment of an antibody specific for AMIGO2 improves immunohistochemical evaluation of liver metastases and clinical outcomes in patients with colorectal cancer. Diagn Pathol 17:16.
Abstract
22: Izutsu R, Osaki M, Nemoto H, Jingu M, Sasaki R, Yoshioka Y, Ochiya T, Okada F, (2022). AMIGO2 contained in cancer cell-derived extracellular vesicles enhances the adhesion of liver endothelial cells to cancer cells. Sci Rep 12:792.
Abstract
21: Hu Y, Zou D, (2021). Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer. PLoS One 16:e0260811.
Abstract
20: Peng XF, Qin FL, Chen WJ, Zhang H, Mai ZY, Zeng J, (2021). The landscape of angiogenesis subtypes for breast cancer: a comprehensive analysis based on the Cancer Genome Atlas. J BUON 26:1975-1990.
Abstract
19: Lopez-Ozuna VM, Kogan L, Hachim MY, Matanes E, Hachim IY, Mitric C, Kiow LLC, Lau S, Salvador S, Yasmeen A, Gotlieb WH, (2021). Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer. Front Oncol 11:695404.
Abstract
18: Berico P, Cigrang M, Davidson G, Braun C, Sandoz J, Legras S, Vokshi BH, Slovic N, Peyresaubes F, Gene Robles CM, Egly JM, Compe E, Davidson I, Coin F, (2021). CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma. EMBO Rep 22:e51683.
Abstract
17: Bi O, Anene CA, Nsengimana J, Shelton M, Roberts W, Newton-Bishop J, Boyne JR, (2021). SFPQ promotes an oncogenic transcriptomic state in melanoma. Oncogene 40:5192-5203.
Abstract
16: Cui Y, Li C, Jiang Z, Zhang S, Li Q, Liu X, Zhou Y, Li R, Wei L, Li L, Zhang Q, Wen L, Tang F, Zhou D, (2021). Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors. Neuro Oncol 23:1859-1871.
Abstract
15: Tanio A, Saito H, Amisaki M, Hara K, Sugezawa K, Uejima C, Tada Y, Kihara K, Yamamoto M, Nosaka K, Sasaki R, Osaki M, Okada F, Fujiwara Y, (2021). AMIGO2 as a novel indicator of liver metastasis in patients with colorectal cancer. Oncol Lett 21:278.
Abstract
14: Liu Y, Yang J, Shi Z, Tan X, Jin N, OBrien C, Ott C, Grisoli A, Lee E, Volk K, Conroy M, Franz E, Bryant A, Campbell L, Crowley B, Grisoli S, Alexandrou AT, Li C, Harper EI, Asem M, Johnson J, Leonard A, Santanello K, Klein A, Wang Q, Zhang S, Hilliard TS, Stack MS, (2021). In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation. Cancer Lett 503:163-173.
Abstract
13: Nakamura S, Kanda M, Shimizu D, Tanaka C, Inokawa Y, Hattori N, Hayashi M, Yamada S, Nakayama G, Omae K, Koike M, Kodera Y, (2020). AMIGO2 Expression as a Potential Prognostic Biomarker for Gastric Cancer. Anticancer Res 40:6713-6721.
Abstract
12: Sonzogni O, Haynes J, Seifried LA, Kamel YM, Huang K, BeGora MD, Yeung FA, Robert-Tissot C, Heng YJ, Yuan X, Wulf GM, Kron KJ, Wagenblast E, Lupien M, Kislinger T, Hannon GJ, Muthuswamy SK, (2018). Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo. PLoS Biol 16:e2004049.
Abstract
11: Ma X, Hu P, Chen H, Fang T, (2019). Loss of AMIGO2 causes dramatic damage to cardiac preservation after ischemic injury. Cardiol J 26:394-404.
Abstract
10: Huo T, Canepa R, Sura A, Modave F, Gong Y, (2017). Colorectal cancer stages transcriptome analysis. PLoS One 12:e0188697.
Abstract
9: Fontanals-Cirera B, Hasson D, Vardabasso C, Di Micco R, Agrawal P, Chowdhury A, Gantz M, de Pablos-Aragoneses A, Morgenstern A, Wu P, Filipescu D, Valle-Garcia D, Darvishian F, Roe JS, Davies MA, Vakoc CR, Hernando E, Bernstein E, (2017). Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene. Mol Cell 68:731-744.e9.
Abstract
8: Shen S, Gui T, Ma C, (2017). Identification of molecular biomarkers for pancreatic cancer with mRMR shortest path method. Oncotarget 8:41432-41439.
Abstract
7: Kanda Y, Osaki M, Onuma K, Sonoda A, Kobayashi M, Hamada J, Nicolson GL, Ochiya T, Okada F, (2017). Amigo2-upregulation in Tumour Cells Facilitates Their Attachment to Liver Endothelial Cells Resulting in Liver Metastases. Sci Rep 7:43567.
Abstract
6: Benedetti G, Bonaventura P, Lavocat F, Miossec P, (2016). IL-17A and TNF-alpha Increase the Expression of the Antiapoptotic Adhesion Molecule Amigo-2 in Arthritis Synoviocytes. Front Immunol 7:254.
Abstract
5: Park H, Lee S, Shrestha P, Kim J, Park JA, Ko Y, Ban YH, Park DY, Ha SJ, Koh GY, Hong VS, Mochizuki N, Kim YM, Lee W, Kwon YG, (2015). AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation. J Cell Biol 211:619-37.
Abstract
4: Tsoi LC, Qin T, Slate EH, Zheng WJ, (2011). Consistent Differential Expression Pattern (CDEP) on microarray to identify genes related to metastatic behavior. BMC Bioinformatics 12:438.
Abstract
3: Kajander T, Kuja-Panula J, Rauvala H, Goldman A, (2011). Crystal structure and role of glycans and dimerization in folding of neuronal leucine-rich repeat protein AMIGO-1. J Mol Biol 413:1001-15.
Abstract
2: Simmen FA, Su Y, Xiao R, Zeng Z, Simmen RC, (2008). The Kruppel-like factor 9 (KLF9) network in HEC-1-A endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression. Reprod Biol Endocrinol 6:41.
Abstract
1: Rabenau KE, OToole JM, Bassi R, Kotanides H, Witte L, Ludwig DL, Pereira DS, (2004). DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity. Oncogene 23:5056-67.
Abstract
Aging (Albany NY) (n=1)
Anticancer Res (n=2)
BMC Bioinformatics (n=1)
BMC Cancer (n=1)
Biomed Res Int (n=1)
Cancer Discov (n=1)
Cancer Gene Ther (n=1)
Cancer Lett (n=1)
Cardiol J (n=1)
Diagn Pathol (n=1)
EMBO Rep (n=1)
Front Immunol (n=2)
Front Oncol (n=1)
Gene (n=1)
Hereditas (n=1)
Int J Clin Oncol (n=1)
J BUON (n=1)
J Cell Biol (n=1)
J Cell Mol Med (n=1)
J Hepatocell Carcinoma (n=1)
J Mol Biol (n=1)
J Pathol (n=1)
Mol Cell (n=1)
Mol Clin Oncol (n=1)
Neuro Oncol (n=1)
Oncogene (n=2)
Oncol Lett (n=2)
Oncotarget (n=1)
PLoS Biol (n=1)
PLoS One (n=2)
Pathol Res Pract (n=1)
Reprod Biol Endocrinol (n=1)
Sci Rep (n=4)
Transl Androl Urol (n=1)
2004 (n=1)
2008 (n=1)
2011 (n=2)
2015 (n=1)
2016 (n=1)
2017 (n=4)
2018 (n=1)
2019 (n=1)
2020 (n=1)
2021 (n=8)
2022 (n=6)
2023 (n=4)
2024 (n=8)
2025 (n=3)
Agrawal P(1), Alexandrou AT(1), Amisaki M(1), Anene CA(1), Asem M(1), Ban YH(1), Bassi R(1), BeGora MD(1), Benedetti G(1), Berico P(1), Bernstein E(1), Bi O(1), Bonaventura P(1), Boyne JR(1), Braun C(1), Bryant A(1), Cai S(1), Cai Z(1), Campbell L(1), Canepa R(1), Cao J(1), Cao SY(1), Cao Y(1), Chen C(1), Chen H(1), Chen J(2), Chen LK(1), Chen S(1), Chen WJ(1), Chen Z(2), Chowdhury A(1), Cigrang M(1), Coin F(1), Compe E(1), Conroy M(1), Crowley B(1), Cui Y(1), Darvishian F(1), Davidson G(1), Davidson I(1), Davies MA(1), Demmler R(1), Deng Y(1), Di Micco R(1), Du W(1), Du Y(1), Egly JM(1), Fang Q(1), Fang T(1), Feng K(1), Feng Y(1), Filipescu D(1), Flierl C(1), Fontanals-Cirera B(1), Franz E(1), Fujiwara Y(3), Gantz M(1), Gass T(1), Gene Robles CM(1), Geppert CI(1), Goldman A(1), Gong X(1), Gong Y(1), Gotlieb WH(1), Goto K(2), Grisoli A(1), Grisoli S(1), Gui T(1), Guo W(1), Ha SJ(1), Hachim IY(1), Hachim MY(1), Hamada J(2), Hamada JI(1), Han D(1), Han Z(1), Hannon GJ(1), Hara K(1), Harper EI(1), Hasson D(1), Hattori N(1), Hayashi A(1), Hayashi M(1), Haynes J(1), Heng YJ(1), Hernando E(1), Hilliard TS(1), Hon CT(1), Hong VS(1), Hou S(1), Hsu D(1), Hu P(1), Hu Y(1), Huang K(1), Huo T(1), Iacobuzio-Donahue CA(1), Iida Y(2), Inokawa Y(1), Ito H(1), Izutsu R(9), Jehung JP(2), Jiang R(1), Jiang W(1), Jiang Z(1), Jin N(1), Jin R(1), Jingu M(1), Johnson J(1), Kajander T(1), Kamel YM(1), Kanda M(1), Kanda Y(2), Kazuki Y(1), Khan AG(1), Kihara K(1), Kim J(1), Kim YM(1), Kiow LLC(1), Kislinger T(1), Klein A(1), Ko Y(1), Kobayashi M(1), Kodera Y(1), Kogan L(1), Koh GY(1), Koike M(1), Komatsu H(2), Kotanides H(1), Kron KJ(1), Kugoh H(1), Kuja-Panula J(1), Kwon YG(1), Lau S(1), Lavocat F(1), Lee E(1), Lee S(1), Lee W(1), Legras S(1), Leonard A(1), Li C(3), Li J(1), Li L(1), Li P(1), Li PF(1), Li Q(1), Li R(1), Li S(1), Liang Y(2), Lin S(1), Lin SP(1), Liu C(1), Liu D(1), Liu HJ(1), Liu K(1), Liu X(1), Liu Y(2), Liu Z(1), Lopez-Ozuna VM(1), Lorenz IC(1), Lu L(1), Ludwig DL(1), Lupien M(1), Ma C(1), Ma X(1), Mai ZY(1), Matanes E(1), Mei W(1), Merkel S(1), Miao TY(1), Miossec P(1), Mitric C(1), Mochizuki N(1), Modave F(1), Morgenstern A(1), Morimoto M(1), Muthuswamy SK(1), Nakamura S(1), Nakayama G(1), Naschberger E(1), Nemoto H(1), Newton-Bishop J(1), Nicolson GL(1), Nosaka K(1), Nsengimana J(1), OBrien C(1), OToole JM(1), Ochiya T(2), Ogata S(1), Okada F(11), Okamoto K(1), Okawa M(1), Omae K(1), Onuma K(1), Osaki M(11), Osaku D(1), Oshimura M(1), Ott C(1), Park DY(1), Park H(1), Park JA(1), Peng XF(1), Pereira DS(1), Petter K(1), Peyresaubes F(1), Qi Y(1), Qin FL(1), Qin T(1), Qiu Y(1), Rabenau KE(1), Rauvala H(1), Ravetch E(1), Robert-Tissot C(1), Roberts W(1), Roe JS(1), Saito H(1), Salvador S(1), Sandoz J(1), Santanello K(1), Sasaki R(3), Sato R(2), Sato S(2), Satofuka H(1), Schellerer VS(1), Seifried LA(1), Seong H(5), Seong HK(1), Shelton M(1), Shen J(1), Shen L(1), Shen S(1), Shen WG(1), Shi Z(1), Shimizu D(1), Shrestha P(1), Simmen FA(1), Simmen RC(1), Slate EH(1), Slovic N(1), Sonoda A(1), Sonzogni O(1), Stack MS(1), Sturzl M(1), Su Y(1), Sugezawa K(1), Sura A(1), Tada Y(1), Takahashi M(1), Tan X(1), Tan XP(1), Tanaka C(1), Tanaka H(1), Tang F(1), Tang Z(1), Taniguchi F(2), Tanio A(3), Tavazoie SF(1), Tian J(1), Tian Z(2), Tsoi LC(1), Uejima C(1), Umeda S(1), Vakoc CR(1), Valle-Garcia D(1), Vardabasso C(1), Vokshi BH(1), Volk K(1), Wagenblast E(1), Wang F(1), Wang Q(1), Wang S(1), Wang Z(1), Wei L(1), Wen L(1), Witte L(1), Wu H(1), Wu P(1), Wu WJ(1), Wu XP(1), Wu YG(1), Wulf GM(1), Xiao R(1), Xie J(2), Xie Y(1), Xie YH(1), Xiong B(1), Xiong BH(1), Xu X(1), Yamada S(1), Yamaguchi N(1), Yamamoto M(2), Yang C(1), Yang J(1), Yang S(1), Yao Z(1), Yasmeen A(1), Ye J(1), Ye XY(1), Yeung FA(1), Yin H(1), Yong Y(1), Yoshioka Y(1), Yuan X(1), Zeng J(1), Zeng XF(1), Zeng Z(1), Zhang C(1), Zhang H(2), Zhang Q(1), Zhang R(1), Zhang S(2), Zhang T(1), Zhang X(1), Zheng WJ(1), Zhong W(1), Zhou B(1), Zhou D(2), Zhou W(1), Zhou Y(2), Zhu CR(1), Zhu K(1), Zhu X(1), Zhu ZF(1), Zhu ZX(1), Zhuo Y(1), Zohud BA(1), Zou D(1), de Pablos-Aragoneses A(1), de Stanchina E(1),
Adenocarcinoma(3), Adenocarcinoma/drug therapy(1), Adenocarcinoma/drug therapy/genetics(1), Adenocarcinoma/genetics(1), Adenocarcinoma/genetics/pathology(1), Adult(1), Aged(3), Aged, 80 and over(1), Algorithms(2), Amino Acid Sequence(2), Amino Acids(1), Amino Acids/metabolism(1), Animals(15), Anthracenes(1), Anthracenes/pharmacology(1), Antineoplastic Agents(1), Antineoplastic Agents/pharmacology(1), Apoptosis(3), Apoptosis Regulatory Proteins(1), Apoptosis Regulatory Proteins/genetics(1), Apoptosis Regulatory Proteins/genetics/metabolism(1), Apoptosis/physiology(1), Base Sequence(1), Benzamides(1), Benzamides/metabolism(1), Biomarkers, Tumor(4), Biomarkers, Tumor/genetics(3), Biomarkers, Tumor/genetics/metabolism(2), Blotting, Western(1), Breast Neoplasms(1), Breast Neoplasms/blood supply(1), Breast Neoplasms/blood supply/genetics(1), C-Reactive Protein(1), CD8-Positive T-Lymphocytes(1), Cancer-Associated Fibroblasts(1), Cancer-Associated Fibroblasts/metabolism(1), Cancer-Associated Fibroblasts/metabolism/pathology(1), Carcinogenesis(1), Carcinogenesis/genetics(1), Carcinoma(1), Carcinoma, Neuroendocrine(1), Carcinoma, Neuroendocrine/genetics(1), Carcinoma, Neuroendocrine/genetics/classification/pathology(1), Carcinoma, Non-Small-Cell Lung(1), Carcinoma, Non-Small-Cell Lung/drug therapy(1), Carcinoma, Non-Small-Cell Lung/drug therapy/genetics(1), Carcinoma, Pancreatic Ductal(2), Carcinoma, Pancreatic Ductal/metabolism(2), Carcinoma, Pancreatic Ductal/metabolism/pathology(1), Carcinoma/genetics(1), Carcinoma/genetics/metabolism(1), Caspase 3(1), Caspase 3/metabolism(1), Cell Adhesion(7), Cell Adhesion Molecules(2), Cell Adhesion Molecules/metabolism(2), Cell Adhesion Molecules/metabolism/genetics(1), Cell Adhesion/drug effects(1), Cell Adhesion/genetics(2), Cell Adhesion/physiology(1), Cell Cycle Proteins(1), Cell Division(1), Cell Division/genetics(1), Cell Hypoxia(1), Cell Line, Tumor(16), Cell Membrane(1), Cell Membrane/metabolism(1), Cell Movement(8), Cell Movement/genetics(2), Cell Proliferation(5), Cell Proliferation/genetics(2), Cell Survival(3), Cell Survival/drug effects(1), Cell Survival/physiology(1), Cells, Cultured(1), Choline(1), Chromosomal Instability(1), Cisplatin(1), Cisplatin/pharmacology(1), Cloning, Molecular(1), Cluster Analysis(1), Cohort Studies(1), Colonic Neoplasms(3), Colonic Neoplasms/drug therapy(1), Colonic Neoplasms/drug therapy/genetics(1), Colonic Neoplasms/genetics(1), Colonic Neoplasms/genetics/metabolism/mortality/pathology(1), Colonic Neoplasms/pathology(1), Colonic Neoplasms/pathology/metabolism/genetics(1), Colorectal Neoplasms(4), Colorectal Neoplasms/genetics(1), Colorectal Neoplasms/pathology(3), Colorectal Neoplasms/pathology/genetics/metabolism(1), Copper(1), Crystallography, X-Ray(1), Cystadenocarcinoma, Serous(1), Cystadenocarcinoma, Serous/pathology(1), Cystadenocarcinoma, Serous/pathology/metabolism(1), DNA Copy Number Variations(1), DNA, Complementary(1), Databases, Genetic(1), Disease Models, Animal(2), Disease-Free Survival(1), Drug Tolerance(1), Endometrial Neoplasms(1), Endometrial Neoplasms/genetics(1), Endometrial Neoplasms/genetics/metabolism(1), Endothelial Cells(6), Endothelial Cells/metabolism(3), Endothelial Cells/metabolism/pathology(1), Endothelial Cells/pathology(1), Endothelial Cells/physiology(1), Enhancer Elements, Genetic(1), Epithelial Cells(1), Epithelial Cells/pathology(1), Epithelial-Mesenchymal Transition(2), Epithelial-Mesenchymal Transition/genetics(1), Esophageal Neoplasms(1), Esophageal Neoplasms/pathology(1), Esophageal Squamous Cell Carcinoma(1), Esophageal Squamous Cell Carcinoma/genetics(1), Esophageal Squamous Cell Carcinoma/genetics/pathology(1), Extracellular Vesicles(2), Extracellular Vesicles/metabolism(2), Extracellular Vesicles/metabolism/physiology(1), Female(10), Gasdermins(1), Gasdermins/drug effects(1), Gasdermins/drug effects/metabolism(1), Gene Expression Profiling(5), Gene Expression Profiling/methods(2), Gene Expression Regulation, Neoplastic(17), Gene Expression Regulation, Neoplastic/drug effects(1), Gene Knockdown Techniques(2), Gene Ontology(1), Gene Regulatory Networks(2), Genes, Reporter(1), Genes, Reporter/genetics(1), Genome(1), Green Fluorescent Proteins(1), Green Fluorescent Proteins/genetics(1), Hepatic Stellate Cells(1), Hepatic Stellate Cells/metabolism(1), Hepatic Stellate Cells/metabolism/pathology(1), Human Umbilical Vein Endothelial Cells(1), Humans(32), Hypoxia-Inducible Factor 1, alpha Subunit(1), Hypoxia-Inducible Factor 1, alpha Subunit/metabolism(1), Immunohistochemistry(2), Interleukin-8(1), Interleukin-8/metabolism(1), Kaplan-Meier Estimate(2), Keratin-14(1), Keratin-14/genetics(1), Keratin-8(1), Keratin-8/genetics(1), Kinesins(1), Kruppel-Like Factor 4(1), Kruppel-Like Transcription Factors(1), Kruppel-Like Transcription Factors/genetics(1), Kruppel-Like Transcription Factors/genetics/metabolism/physiology(1), Leucine(1), Leucine-Rich Repeat Proteins(1), Linear Models(1), Liver(1), Liver Neoplasms(8), Liver Neoplasms/etiology(1), Liver Neoplasms/etiology/metabolism/secondary(1), Liver Neoplasms/metabolism(1), Liver Neoplasms/metabolism/pathology/secondary/genetics(1), Liver Neoplasms/pathology(1), Liver Neoplasms/secondary(5), Liver Neoplasms/secondary/metabolism(2), Liver Neoplasms/secondary/metabolism/drug therapy/prevention & control/genetics(1), Liver/cytology(1), Logistic Models(1), Lung Neoplasms(1), Lung Neoplasms/drug therapy(1), Lung Neoplasms/drug therapy/genetics(1), Machine Learning(1), Macrophages(1), Macrophages/metabolism(1), Male(5), Mammary Glands, Animal(1), Mammary Glands, Animal/cytology(1), Mammary Glands, Animal/cytology/pathology(1), Mammary Neoplasms, Animal(1), Mammary Neoplasms, Animal/genetics(1), Mammary Neoplasms, Animal/genetics/pathology(1), Melanoma(3), Melanoma/drug therapy(2), Melanoma/drug therapy/genetics(1), Melanoma/drug therapy/genetics/metabolism/pathology(1), Melanoma/genetics(1), Melanoma/genetics/pathology/metabolism(1), Membrane Proteins(7), Membrane Proteins/chemistry(1), Membrane Proteins/chemistry/genetics/metabolism(1), Membrane Proteins/deficiency(1), Membrane Proteins/deficiency/genetics(1), Membrane Proteins/genetics(3), Membrane Proteins/genetics/metabolism(2), Membrane Proteins/metabolism(2), Membrane Proteins/metabolism/genetics(1), Meta-Analysis as Topic(1), Methyltransferases(1), Methyltransferases/genetics(1), Methyltransferases/genetics/metabolism(1), Mice(14), Mice, Inbred BALB C(1), Mice, Inbred C57BL(1), Mice, Knockout(1), Mice, Nude(3), Mice, Transgenic(1), MicroRNAs(1), MicroRNAs/genetics(1), Microphthalmia-Associated Transcription Factor(1), Microphthalmia-Associated Transcription Factor/genetics(1), Microphthalmia-Associated Transcription Factor/genetics/metabolism(1), Middle Aged(4), Models, Biological(1), Molecular Docking Simulation(1), Molecular Sequence Data(2), Multiomics(1), Mutagenesis, Site-Directed(1), Mutation(2), Mutation/genetics(1), Myocardial Infarction(1), Myocardial Infarction/genetics(1), Myocardial Infarction/genetics/metabolism/pathology/physiopathology(1), Myocytes, Cardiac(1), Myocytes, Cardiac/metabolism(1), Myocytes, Cardiac/metabolism/pathology(1), NF-kappa B(1), NF-kappa B/metabolism(1), Neoplasm Invasiveness(1), Neoplasm Metastasis(5), Neoplasm Metastasis/pathology(2), Neoplasm Proteins(1), Neoplasm Proteins/metabolism(1), Neoplasm Transplantation(1), Neoplasms(1), Neoplasms, Experimental(1), Neoplasms, Experimental/etiology(1), Neoplasms/genetics(1), Neoplasms/genetics/pathology(1), Neovascularization, Pathologic(2), Neovascularization, Pathologic/classification(1), Neovascularization, Pathologic/metabolism(1), Neovascularization, Physiologic(1), Nerve Tissue Proteins(16), Nerve Tissue Proteins/deficiency(1), Nerve Tissue Proteins/deficiency/genetics(1), Nerve Tissue Proteins/genetics(10), Nerve Tissue Proteins/genetics/metabolism(7), Nerve Tissue Proteins/metabolism(5), Neuroendocrine Tumors(2), Neuroendocrine Tumors/genetics(2), Neuroendocrine Tumors/genetics/classification/pathology(1), Neurons(1), Neurons/cytology(1), Neurons/cytology/metabolism(1), Nitriles(1), Nuclear Proteins(1), Nuclear Proteins/genetics(1), Nuclear Proteins/genetics/metabolism(1), Oligonucleotide Array Sequence Analysis(2), Oligonucleotide Array Sequence Analysis/methods(1), Ovarian Neoplasms(2), Ovarian Neoplasms/genetics(1), Ovarian Neoplasms/genetics/metabolism/pathology(1), Ovarian Neoplasms/pathology(1), Ovarian Neoplasms/pathology/genetics(1), PPAR gamma(1), PPAR gamma/genetics(1), PPAR gamma/genetics/metabolism(1), PTB-Associated Splicing Factor(1), PTB-Associated Splicing Factor/genetics(1), PTB-Associated Splicing Factor/genetics/metabolism(1), PTEN Phosphohydrolase(1), PTEN Phosphohydrolase/genetics(1), PTEN Phosphohydrolase/genetics/metabolism(1), Pancreas(1), Pancreatic Neoplasms(4), Pancreatic Neoplasms/diagnosis(2), Pancreatic Neoplasms/diagnosis/genetics(1), Pancreatic Neoplasms/diagnosis/genetics/metabolism(1), Pancreatic Neoplasms/pathology(2), Pancreatic Neoplasms/pathology/metabolism/drug therapy(1), Paracrine Communication(1), Peritoneal Neoplasms(2), Peritoneal Neoplasms/genetics(1), Peritoneal Neoplasms/genetics/metabolism/pathology/secondary(1), Peritoneal Neoplasms/secondary(1), Peritoneal Neoplasms/secondary/genetics(1), Peritoneum(1), Peritoneum/pathology(1), Phosphatidylethanolamine N-Methyltransferase(1), Phosphatidylinositol 3-Kinases(1), Phosphatidylinositol 3-Kinases/metabolism(1), Pituitary Gland(1), Pituitary Neoplasms(1), Pituitary Neoplasms/genetics(1), Ploidies(1), Polysaccharides(1), Polysaccharides/chemistry(1), Polysaccharides/chemistry/metabolism(1), Principal Component Analysis(1), Prognosis(10), Promoter Regions, Genetic(1), Promoter Regions, Genetic/genetics(1), Proportional Hazards Models(1), Prostatic Neoplasms(1), Prostatic Neoplasms/genetics(1), Prostatic Neoplasms/genetics/classification/pathology(1), Protein Conformation(1), Protein Folding(1), Protein Interaction Maps(1), Protein Interaction Maps/genetics(1), Protein Multimerization(1), Protein Serine-Threonine Kinases(2), Protein Serine-Threonine Kinases/genetics(1), Protein Serine-Threonine Kinases/genetics/metabolism(1), Protein Serine-Threonine Kinases/metabolism(1), Proteins(1), Proteins/chemistry(1), Proteins/chemistry/genetics/metabolism(1), Proto-Oncogene Proteins c-akt(2), Proto-Oncogene Proteins c-akt/genetics(1), Proto-Oncogene Proteins c-akt/genetics/metabolism(1), Proto-Oncogene Proteins c-akt/metabolism(1), Pyrazoles(2), Pyrazoles/pharmacology(2), Pyridones(1), Pyridones/pharmacology(1), Pyrimidines(1), Pyrimidines/pharmacology(1), Pyrimidinones(1), Pyrimidinones/pharmacology(1), Pyroptosis(1), Pyrroles(1), Pyrroles/pharmacology(1), Pyruvate Dehydrogenase Acetyl-Transferring Kinase(2), Pyruvate Dehydrogenase Acetyl-Transferring Kinase/genetics(1), Pyruvate Dehydrogenase Acetyl-Transferring Kinase/genetics/metabolism(1), RNA Precursors(1), RNA Precursors/metabolism(1), RNA Splicing Factors(1), RNA Splicing Factors/genetics(1), RNA, Long Noncoding(1), RNA, Long Noncoding/genetics(1), RNA, Messenger(3), RNA, Messenger/genetics(2), RNA, Messenger/genetics/metabolism(2), RNA, Messenger/metabolism(1), ROC Curve(1), Rats(1), Receptor Protein-Tyrosine Kinases(1), Receptor Protein-Tyrosine Kinases/metabolism(1), Reverse Transcriptase Polymerase Chain Reaction(1), Risk Factors(1), Sequence Homology, Amino Acid(1), Sequence Homology, Nucleic Acid(1), Signal Transduction(8), Signal Transduction/drug effects(1), Signal Transduction/genetics(1), Signal Transduction/physiology(1), Single-Cell Analysis(1), Statistics as Topic(1), Stomach Neoplasms(7), Stomach Neoplasms/diagnosis(1), Stomach Neoplasms/diagnosis/pathology(1), Stomach Neoplasms/genetics(3), Stomach Neoplasms/genetics/metabolism/mortality/pathology(1), Stomach Neoplasms/genetics/pathology(1), Stomach Neoplasms/pathology(3), Stomach Neoplasms/pathology/metabolism/drug therapy/genetics(1), Stomach Neoplasms/pathology/metabolism/genetics(1), Survival Analysis(1), Transcription Factors(1), Transcription Factors/genetics(1), Transcription Factors/genetics/metabolism(1), Transcriptome(4), Transcriptome/genetics(1), Transforming Growth Factor beta(2), Transforming Growth Factor beta/metabolism(2), Triple Negative Breast Neoplasms(1), Triple Negative Breast Neoplasms/diagnosis(1), Triple Negative Breast Neoplasms/diagnosis/genetics/mortality(1), Tumor Cells, Cultured(2), Tumor Microenvironment(2), Tumor Microenvironment/genetics(1), Tumor Suppressor Protein p53(1), Tumor Suppressor Protein p53/genetics(1), Up-Regulation(2), Urinary Bladder Neoplasms(1), Urinary Bladder Neoplasms/genetics(1), Urinary Bladder Neoplasms/genetics/pathology/metabolism(1), Vascular Endothelial Growth Factor A(1), Vascular Endothelial Growth Factor A/genetics(1), Vascular Endothelial Growth Factor A/genetics/metabolism(1), Ventricular Function, Left(1),
This Citation list has been generated on 2025/06/26 by PubReMiner CV Output: PubReMiner